gms | German Medical Science

67th Annual Meeting of the German Society of Neurosurgery (DGNC)
Joint Meeting with the Korean Neurosurgical Society (KNS)

German Society of Neurosurgery (DGNC)

12 - 15 June 2016, Frankfurt am Main

Adipose cell-derived stem cells in a rat posterolateral spine fusion model

Meeting Abstract

Search Medline for

  • Ralf D. Rothoerl - Klinik für Neurochirurgie, Isarklinikum München, Germany; Zentrum für Regenerative Medizin und Sportmedizin, Isarklinikum München, Germany
  • Christopher Alt - Zentrum für Regenerative Medizin und Sportmedizin, Isarklinikum München, Germany
  • Eckhard Alt - Zentrum für Regenerative Medizin und Sportmedizin, Isarklinikum München, Germany

Deutsche Gesellschaft für Neurochirurgie. 67. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), 1. Joint Meeting mit der Koreanischen Gesellschaft für Neurochirurgie (KNS). Frankfurt am Main, 12.-15.06.2016. Düsseldorf: German Medical Science GMS Publishing House; 2016. DocDI.04.08

doi: 10.3205/16dgnc117, urn:nbn:de:0183-16dgnc1171

Published: June 8, 2016

© 2016 Rothoerl et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.


Outline

Text

Objective: Recent interest has been directed toward adipose-derived stem cells (ADSCs), which have been utilized in stand-alone cell-based therapies for bone repair. Although rhBMPs have been used successfully to induce spinal fusion, unforeseen biological effects have been reported. Alternative tissue engineering strategies including cell-based therapies show a number of potential advantages and are therefore being explored. Aim of our study was to compare the bone-formation potential of stem cells derived from human fat when used with either rhBMP2 or as a cell-based therapy alone in a rat posterolateral spine fusion model.

Method: 30 rats, (age 12-16 weeks, 300-350g), were randomized into 3 different groups for this study. In group I collagen tissue (MatryStypt®) was implanted, in group II ADSCs were implanted on the collagen carrier. In group III, ADSCs cultured in 1 μg/mL of rhBMP-2 and osteogenic media were implanted. The rats were anesthetized. Adipose tissue was obtained from the inguinal fat and then prepared due to an InGeneron® protocol. After a posterior midline incision, two separate fascial incisions were made 4 mm from the midline and the transverse processes were then exposed. A high-speed burr was used to decorticate the transverse processes. Graft materials were saturated with a type-I collagen sponge and then implanted between the transverse processes bilaterally. Animals were housed in separate cages and allowed to eat, drink, and bear weight ad libitum. 6 weeks after treatment anteroposterior radiographs were made. Animals were sacrificed and subjected to manual testing. The harvested spines were evaluated for evidence of successful fusion by independent observers using a previously published scoring system. Furthermore histological analysis and micro CT was performed.

Results: All spines in Groups II and III (ADSCs, ADSCs+rhBMP2) were fused in the plain x-rays at six weeks postoperatively. In contrast, none of the spines in the group I (collagen alone) had fused according the plain X-rays. Furthermore solid fusion according to the motion test, histology and micro CT occurred in Group II and III but not in Group I.

Conclusions: The present study suggests that ADSCs induce the formation of new bone in experimental spinal fusion alone without the need for rhBMP-2.